Cargando…

Inotuzumab ozogamicin for acute lymphoblastic leukaemia

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698239/
https://www.ncbi.nlm.nih.gov/pubmed/31427847
http://dx.doi.org/10.18773/austprescr.2019.046
_version_ 1783444513795080192
collection PubMed
description
format Online
Article
Text
id pubmed-6698239
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-66982392019-08-19 Inotuzumab ozogamicin for acute lymphoblastic leukaemia Aust Prescr New Drug NPS MedicineWise 2019-06-17 2019-08 /pmc/articles/PMC6698239/ /pubmed/31427847 http://dx.doi.org/10.18773/austprescr.2019.046 Text en (c) NPS MedicineWise 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drug
Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title_full Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title_fullStr Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title_full_unstemmed Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title_short Inotuzumab ozogamicin for acute lymphoblastic leukaemia
title_sort inotuzumab ozogamicin for acute lymphoblastic leukaemia
topic New Drug
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698239/
https://www.ncbi.nlm.nih.gov/pubmed/31427847
http://dx.doi.org/10.18773/austprescr.2019.046